A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Rondo Therapeutics
Carisma Therapeutics Inc
Nimbus Therapeutics
KitovPharma
Gary Onik MD
University of Utah